Early clinical response in patients with migraine in treatment with anti-CGRP monoclonal antibodies: a possible "loading dose" effect?

被引：0
|
作者：
Ceccardi, Giulia
di Cola, Francesca Schiano
Bolchini, Marco
Di Pasquale, Michele
Rao, Renata
Padovani, Alessandro
机构：
[1] ASST Spedali Civili, Neurol Unit, Brescia, Italy
[2] ASST Spedali Civili, Headache Ctr, Dipartimento Continuita Cura & Fragilita, Brescia, Italy
[3] Univ Brescia, Brescia, Italy
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-2
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [31] Anti-CGRP Monoclonal Antibodies: the Next Era of Migraine Prevention?
    Tso, Amy R.
    Goadsby, Peter J.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2017, 19 (08)
  • [32] Effectiveness of anti-CGRP monoclonal antibodies on central symptoms of migraine
    Iannone, Luigi Francesco
    De Cesaris, Francesco
    Ferrari, Anita
    Benemei, Silvia
    Fattori, Davide
    Chiarugi, Alberto
    CEPHALALGIA, 2022, 42 (13) : 1323 - 1330
  • [33] Switching between anti-CGRP monoclonal antibodies in migraine prophylaxis
    Vikelis, Michail
    Rikos, Dimitrios
    Argyriou, Andreas A.
    Dermitzakis, Emmanouil V.
    Andreou, Anna P.
    Russo, Antonio
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2025,
  • [34] An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine
    Romozzi, Marina
    Lokhandwala, Ammar
    Vollono, Catello
    Vigani, Giulia
    Burgalassi, Andrea
    Garcia-Azorin, David
    Calabresi, Paolo
    Chiarugi, Alberto
    Geppetti, Pierangelo
    Iannone, Luigi Francesco
    CEPHALALGIA, 2024, 44 (12)
  • [35] Eptinezumab Anti-CGRP monoclonal antibody Treatment of migraine
    Lu, Lingyun
    Liu, Meijun
    Hu, Songshan
    Liu, Yao
    Yang, Dongdong
    Hong, Peiwei
    DRUGS OF THE FUTURE, 2017, 42 (10) : 609 - 615
  • [36] DO MULTIPLE TREATMENT CYCLES WITH ANTI-CGRP MONOCLONAL ANTIBODIES MODIFY MIGRAINE COURSE?
    Aurilia, C.
    Egeo, G.
    Proietti, S.
    Torelli, P.
    Cevoli, S.
    D'Onofrio, F.
    Bonassi, S.
    Barbanti, P.
    HEADACHE, 2023, 63 : 126 - 126
  • [37] Anti-CGRP Monoclonal Antibodies for the Treatment of Migraine with Aura: a prospective observational cohort study
    Braca, S.
    Russo, C.
    Miele, A.
    Stornaiuolo, A.
    Sansone, M.
    De Simone, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 376 - 376
  • [38] Work impact and cost-effectiveness of anti-CGRP monoclonal antibodies in patients with migraine
    Lazaro, C.
    Caronna, E.
    Alpuente, A.
    De la Torre, A.
    Torres, M.
    Pozo-Roisch, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 487 - 488
  • [39] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Lovati, Carlo
    Bernasconi, Gianna
    Capogrosso, Chiara
    Molteni, Laura
    Giorgetti, Federica
    Dell'Osso, Bernardo
    Pantoni, Leonardo
    NEUROLOGICAL SCIENCES, 2022, 43 (09) : 5765 - 5767
  • [40] Personality traits and efficacy of anti-CGRP monoclonal antibodies in migraine prevention
    Carlo Lovati
    Gianna Bernasconi
    Chiara Capogrosso
    Laura Molteni
    Federica Giorgetti
    Bernardo Dell’Osso
    Leonardo Pantoni
    Neurological Sciences, 2022, 43 : 5765 - 5767
12345